Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cognition Therapeutics, Inc. - Common Stock (NQ:CGTX)

0.5788 +0.1738 (+42.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 43,047,700
Open 0.4500
Bid (Size) 0.6000 (23)
Ask (Size) 0.6011 (3)
Prev. Close 0.4050
Today's Range 0.4306 - 0.6090
52wk Range 0.2223 - 2.535
Shares Outstanding 61,974,755
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Monday's after hours session: top gainers and losers
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill

Performance

YTD
-20.0%
-20.0%
1 Month
+91.5%
+91.5%
3 Month
+66.8%
+66.8%
6 Month
-32.1%
-32.1%
1 Year
-69.2%
-69.2%

More News

Read More
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Which stocks are moving after the closing bell on Friday?
Via Chartmill
Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data
Via Benzinga
Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Top movers in Thursday's after hours session
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Cognition Therapeutics Study of Zervimesine (CT1812) in Early Alzheimer’s Disease Surpasses 50% Enrollment Target
From Cognition Therapeutics, Inc.
Via GlobeNewswire
Cognition Therapeutics Provides Regulatory Update on Zervimesine (CT1812) in Alzheimer’s Disease and Dementia with Lewy Bodies (DLB)
From Cognition Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
These stocks are moving in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Philanthropic Donor Funds Cognition Therapeutics’ Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
From Cognition Therapeutics, Inc.
Via GlobeNewswire
Cognition Therapeutics Presented Data at Association for Research in Vision and Ophthalmology Showing Impact on Retinal Cell Health
From Cognition Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Cognition Therapeutics Reports Topline Results Showing Oral Zervimesine (CT1812) Reduced Lesion Growth in Phase 2 Study in Geographic Atrophy
From Cognition Therapeutics, Inc.
Via GlobeNewswire
Cognition Therapeutics Reports Financial Results for the First Quarter 2025 and Provides Business Update
From Cognition Therapeutics, Inc.
Via GlobeNewswire
Cognition Therapeutics Presents Results at AD/PD 2025 Showing Impact of Zervimesine (CT1812) on Alzheimer’s Disease Processes
From Cognition Therapeutics, Inc.
Via GlobeNewswire
Cognition Therapeutics to Report Biomarker Results from Phase 2 SHINE Study in Mild-to-Moderate Alzheimer’s Disease in Podium Presentation at AD/PD 2025
From Cognition Therapeutics, Inc.
Via GlobeNewswire
Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update
From Cognition Therapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Cognition Therapeutics, Inc. - Common Stock publicly traded?
Yes, Cognition Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Cognition Therapeutics, Inc. - Common Stock trade on?
Cognition Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cognition Therapeutics, Inc. - Common Stock?
The ticker symbol for Cognition Therapeutics, Inc. - Common Stock is CGTX on the Nasdaq Stock Market
What is the current price of Cognition Therapeutics, Inc. - Common Stock?
The current price of Cognition Therapeutics, Inc. - Common Stock is 0.5788
When was Cognition Therapeutics, Inc. - Common Stock last traded?
The last trade of Cognition Therapeutics, Inc. - Common Stock was at 07/07/25 04:00 PM ET
What is the market capitalization of Cognition Therapeutics, Inc. - Common Stock?
The market capitalization of Cognition Therapeutics, Inc. - Common Stock is 35.87M
How many shares of Cognition Therapeutics, Inc. - Common Stock are outstanding?
Cognition Therapeutics, Inc. - Common Stock has 36M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.